BioLineRx Ltd. (NASDAQ:BLRX) Q4 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Fourth Quarter and Full Year 2024 Financial Results Conference Call.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Highbridge Capital Management Glenn Russell Dubin | 25,250.3 | $214,628 | 0% | |
2. | 1,877.5 | $15,959 | +62% | 0% | |
3. | Citadel Investment Group Ken Griffin | 382.85 | $3,254 | 0% | |
4. | 127.5 | $1,084 | -20% | 0% | |
5. | Alyeska Investment Group Anand Parekh | 0 | $0 | 0% |